Other
Granted (in shares)
West Pharmaceutical Services Granted (in shares) increased by 3251.0% to $254.34 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.5%, from $211.00 to $254.34.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026Apr 23, 2026
How to read this metric
Trends in share grants help investors model future share count dilution and assess the intensity of management's equity-based compensation.
Detailed definition
This metric represents the aggregate number of shares granted under specific share-based payment arrangements, often use...
Peer comparison
Standard disclosure for companies with active equity compensation programs.
Metric ID:
other_share_based_compensation_arrangements_by_share_bas_099e66Historical Data
11 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.73 | $2.21 | $369.13 | $306.68 | $0.24 | $350.18 | $0.10 | $211.00 | $0.39 | $7.59 | $254.34 |
| QoQ Change | — | +202.7% | >999% | -16.9% | -99.9% | >999% | -100.0% | >999% | -99.8% | >999% | >999% |
| YoY Change | — | — | — | -16.9% | — | +14.2% | -58.3% | -39.7% | +290.0% | — | +20.5% |
Range$0.10 – $369.13
CAGR+939.5%
Avg YoY Growth+35.0%
Median YoY Growth-1.4%
Current Streak2 quarters growth
Granted (in shares) at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's granted (in shares)?
- West Pharmaceutical Services (WST) reported granted (in shares) of $254.34 in Q1 2026.
- How has West Pharmaceutical Services's granted (in shares) changed year-over-year?
- West Pharmaceutical Services's granted (in shares) increased by 20.5% year-over-year, from $211.00 to $254.34.
- What does granted (in shares) mean?
- The total number of shares issued or granted under specific equity compensation plans.